10.2460/ajvr.2001.62.1557 19 DahlgrenL
FDA's April 30, 2026 Proposal On April 30, 2026, the FDA announced a proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List, finding no clinical need for outsourcing facilities to compound these drugs from bulk drug substances when FDA-approved versions are available
From the moment you walk in, everyone is welcoming, kind, and genuinely invested in your recovery and wellbeing
Opioids Opioids are drugs that can be prescribed by doctors to treat pain, such as oxycodone (OxyContin), hydrocodone (Vicodin), morphine (Arymo), and methadone (Dolophine), according to the Centers for Disease Control and Prevention (CDC)
Ongoing monitoring: Regular check-ins help ensure you are continuing to respond well and can address any questions or concerns that arise